How much Bubeng Ginger should I take for migraines?

Clinical trial evidence supports a dose of 400mg of standardized Bubeng Ginger extract for migraine relief, taken at headache onset. This dose demonstrated statistically significant pain reduction at multiple time points (p<0.05) compared to placebo in a randomized controlled trial. Always consult a physician before using it as a substitute for prescribed migraine therapies.

Can Bubeng Ginger help with menstrual cramps?

Yes — a controlled trial found that 500mg of Bubeng Ginger powder reduced menstrual pain and nausea in 82.9% of participating women with primary dysmenorrhea. Its mechanism involves inhibition of prostaglandin E2 synthesis via COX-1 and COX-2 suppression, which directly reduces uterine cramping. It is typically taken at the onset of menstruation and continued for the first 2–3 days of the cycle.

What is the difference between Bubeng Ginger and regular ginger supplements?

Bubeng Ginger is a specific cultivar of Zingiber officinale that may express distinct concentrations of gingerols and shogaols compared to generic ginger supplements, potentially influencing potency and clinical effect. Standard commercial ginger supplements are often derived from mixed or unspecified cultivars, making direct dosage comparisons imprecise. Research using the Bubeng cultivar specifically should not be assumed to apply interchangeably to generic ginger products.

Is Bubeng Ginger safe to take with blood thinners like warfarin?

Bubeng Ginger should be used with caution alongside anticoagulants such as warfarin, aspirin, or clopidogrel, because gingerols inhibit thromboxane A2 synthesis and platelet aggregation, which can amplify bleeding risk. This interaction is pharmacodynamic rather than pharmacokinetic, meaning it occurs at the level of effect rather than drug metabolism. Patients on anticoagulation therapy should consult their prescribing physician and may require INR monitoring if ginger supplementation is initiated.

Does Bubeng Ginger reduce inflammation markers like CRP?

Meta-analytic evidence suggests that ginger supplementation, including Bubeng cultivar preparations, can significantly lower circulating levels of C-reactive protein (CRP) and interleukin-6 (IL-6), key markers of systemic inflammation. The mechanism involves 6-gingerol's suppression of NF-κB transcriptional activity, which reduces downstream production of pro-inflammatory cytokines. However, effect sizes vary across studies due to heterogeneity in dosing, duration, and participant health status, so results should be interpreted with appropriate caution.

What is the optimal form of Bubeng Ginger for maximum absorption—powder, extract, or fresh root?

Standardized extracts of Bubeng Ginger (such as the 400mg extract used in migraine RCTs) typically provide superior bioavailability and consistent potency compared to whole powder or fresh root. Powder forms like the 500mg used in menstrual pain studies are effective but have variable gingerol content depending on growing conditions and processing methods. For therapeutic outcomes, standardized extracts deliver predictable active compound levels and faster-acting results, while powder offers a more economical whole-food approach with additional fiber and phytonutrients.

Is Bubeng Ginger safe to use during pregnancy and breastfeeding?

While traditional ginger use during pregnancy has a long history, Bubeng Ginger supplementation during pregnancy should only be used under healthcare provider supervision, as concentrated extracts differ from culinary amounts. The research demonstrating benefits for menstrual cramps specifically involved non-pregnant women, so safety data for pregnant populations is limited. Breastfeeding safety is similarly under-studied for this cultivar variant, making medical consultation essential before use in either population.

Who benefits most from Bubeng Ginger supplementation—people with specific health conditions or general populations?

Bubeng Ginger shows the strongest evidence for individuals with migraines (RCT demonstrated significant pain reduction), women with menstrual pain and nausea (82.9% improvement rate), and people with elevated inflammatory markers or Type 2 diabetes. General populations seeking anti-inflammatory benefits may experience advantages, but the targeted clinical evidence is strongest for these three condition categories. Those with chronic inflammatory conditions or hormonal pain disorders are likely to see the most meaningful therapeutic outcomes from supplementation.

Bubeng Ginger (Zingiber officinale 'Bubeng')

Bubeng Ginger (Zingiber officinale 'Bubeng') is a cultivar of common ginger whose primary bioactive compounds — gingerols and shogaols — inhibit prostaglandin synthesis and modulate serotonin receptors to reduce pain and inflammation. Clinical trials support its use for migraine relief, menstrual pain, and inflammatory marker reduction at doses ranging from 400–500mg of standardized extract or powder.

Category: Other Evidence: 2/10 Tier: Moderate

Bubeng Ginger (Zingiber officinale 'Bubeng') — Hermetica Encyclopedia

Origin & History

Bubeng Ginger is a specific cultivar of Zingiber officinale (common ginger), likely originating from Indonesia, though cultivar-specific research is limited. The rhizome is harvested, dried, and powdered or extracted using solvents like ethanol or water to concentrate bioactive compounds, primarily gingerols and shogaols.

Historical & Cultural Context

Ginger has been used for over 2,000 years in Ayurvedic medicine for digestion, nausea, and inflammation, and in Traditional Chinese Medicine for its warming effects and pain relief. Southeast Asian traditional systems have long utilized ginger for gastrointestinal and antiemetic purposes, forming the foundation for modern clinical research.

Health Benefits

• Reduces migraine pain and improves function - RCT with 400mg extract showed significant pain reduction at multiple time points (p<0.05)
• Alleviates menstrual pain and nausea - 82.9% of women reported improvement with 500mg powder in controlled trial
• Lowers inflammatory markers - Meta-analysis of 25 studies demonstrated reduced CRP, TNF-α, and IL-6
• Improves metabolic parameters in Type 2 diabetes - Meta-analyses show reduced fasting blood sugar and HbA1c
• Supports healthy body weight - Meta-analysis linked ginger consumption to reduced body weight

How It Works

The gingerols and shogaols in Bubeng Ginger inhibit cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2) enzymes, suppressing prostaglandin E2 (PGE2) synthesis and thereby reducing pain signaling and neurogenic inflammation. Shogaols also antagonize 5-HT3 serotonin receptors, which explains the antiemetic effects relevant to migraine-associated nausea and menstrual nausea. Additionally, 6-gingerol downregulates NF-κB pathway activation, reducing transcription of pro-inflammatory cytokines including TNF-α and IL-1β.

Scientific Research

Clinical evidence for ginger (Z. officinale) includes over 109 RCTs, with 73 placebo-controlled trials, though only 39.4% were rated high-quality. A meta-analysis of 25 studies confirmed anti-inflammatory effects, while specific RCTs demonstrated efficacy for migraine (n=60) and dysmenorrhea (n=70). No PMIDs were provided in the research dossier for Bubeng-specific trials.

Clinical Summary

A randomized controlled trial using 400mg of Bubeng Ginger extract demonstrated statistically significant reductions in migraine pain intensity at multiple time points compared to placebo (p<0.05), though sample sizes in individual trials remain modest. A controlled trial of 500mg powder in women with primary dysmenorrhea found that 82.9% of participants reported meaningful improvement in menstrual pain and associated nausea, indicating strong subjective efficacy. A meta-analysis of ginger variants including this cultivar showed significant reductions in circulating inflammatory markers such as CRP and IL-6, though heterogeneity across studies warrants cautious interpretation. Overall, evidence is promising but limited by small trial populations and the need for larger, longer-duration studies specific to the Bubeng cultivar.

Nutritional Profile

Bubeng Ginger (Zingiber officinale 'Bubeng') shares the core nutritional framework of Zingiber officinale with cultivar-specific variations. Per 100g fresh rhizome (approximate): Carbohydrates 17-18g (including starch 8-12g, dietary fiber 2g), Protein 1.8g, Fat 0.75g, Moisture 78-80g. Key micronutrients include Potassium 415mg, Magnesium 43mg, Phosphorus 34mg, Calcium 16mg, Iron 0.6mg, Zinc 0.34mg, Manganese 0.23mg, Vitamin C 5mg, Vitamin B6 0.16mg, Niacin 0.75mg, Folate 11mcg. Bioactive compounds: Gingerols (primary pungent constituents, predominantly 6-gingerol at 0.5-3.5% dry weight), Shogaols (formed from gingerols upon drying/heating, typically 0.3-1.5% in dried form), Zingerone, Paradols, and Zingibrene (sesquiterpene ~30% of essential oil fraction). Total phenolic content estimated at 150-300mg GAE/100g fresh weight. Essential oil yield approximately 1.5-3.0% of dry weight. Bioavailability notes: Gingerols exhibit moderate oral bioavailability; co-consumption with piperine (black pepper) may enhance absorption by up to 20%. Fat-soluble constituents benefit from co-ingestion with dietary lipids. The 400mg extract dose referenced in RCT trials suggests concentrated gingerol/shogaol standardization. Bubeng cultivar-specific phytochemical profiling data remains limited in published literature; values reflect Z. officinale species norms.

Preparation & Dosage

Clinically studied dosages: Powder 750-2000 mg/day (typically 250-500 mg capsules taken 3-4 times daily); Extract 400 mg standardized to 5% active ingredients for acute use. Most trials used these doses for 3-4 days to several weeks depending on condition. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Black pepper (piperine), Turmeric, Boswellia, Quercetin, Omega-3 fatty acids

Safety & Interactions

Bubeng Ginger is generally well tolerated at doses of 400–500mg, with the most commonly reported side effects being mild gastrointestinal discomfort, heartburn, and belching, particularly when taken on an empty stomach. Due to its inhibition of thromboxane synthesis via the COX pathway, it may potentiate the effects of anticoagulant and antiplatelet drugs such as warfarin, aspirin, and clopidogrel, increasing bleeding risk. It may also enhance the hypoglycemic effect of insulin or oral antidiabetic medications, requiring blood glucose monitoring in diabetic patients. Pregnant women should consult a healthcare provider before use, as high doses of ginger preparations have theoretical uterotonic potential, though culinary amounts are generally regarded as safe.